BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8928064)

  • 21. [Analysis of DNA aneuploidy as a tumor marker].
    Takamoto S; Kato H
    Rinsho Ketsueki; 1990 Jun; 31(6):729-35. PubMed ID: 2214164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of DNA distribution abnormalities with cytogenetic findings in human adult leukemia and lymphoma.
    Barlogie B; Hittelman W; Spitzer G; Trujilo JM; Hart JS; Smallwood L; Drewinko B
    Cancer Res; 1977 Dec; 37(12):4400-7. PubMed ID: 922731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DNA aneuploidy in children with acute leukemia: II. Correlation with the phenotype of blasts, clinical picture and course of disease].
    Ritter J; Hiddemann W; Wörmann B; Büchner T; Schellong G
    Klin Padiatr; 1985; 197(3):221-4. PubMed ID: 3892150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the stability of the parameters of the bone marrow cell cycle in hematologic diseases].
    Shmarov DA; Kuchma IuM; Kozinets GI
    Ter Arkh; 1997; 69(7):17-21. PubMed ID: 9424752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal residual disease testing of acute leukemia by flow cytometry immunophenotyping: a retrospective comparison of detection rates with flow cytometry DNA ploidy or FISH-based methods.
    Zwick D; Cooley L; Hetherington M
    Lab Hematol; 2006; 12(2):75-81. PubMed ID: 16751134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New findings in the diagnosis of minimal residual disease in acute leukemia with emphasis on flow cytometry].
    Vosková D; Váleková L; Kubisz P
    Vnitr Lek; 1997 May; 43(5):332-6. PubMed ID: 9601859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
    Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
    Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined metaphase, interphase cytogenetic, and flow cytometric analysis of DNA content of pediatric acute lymphoblastic leukemia.
    Pajor L; Szuhai K; Mehes G; Kosztolányi G; Jáksó P; Lendvai G; Szanyi I; Kajtár P
    Cytometry; 1998 Apr; 34(2):87-94. PubMed ID: 9579606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of residual aneuploid leukemic cells by "continuous gating".
    Kleine HD; Zech I; Nowak R; Oelschlägel U; Kundt G; Freund M
    Cytometry; 1999 May; 36(1):71-6. PubMed ID: 10331629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy.
    Fukunaga M
    Gynecol Oncol; 2001 Apr; 81(1):67-70. PubMed ID: 11277652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Simultaneous determination of cellular DNA and proteins by cytofluorimetry. Application to acute leukemia in adults].
    Ffrench M; Fiere D; Bryon PA; Cordier G; Viala JJ
    Pathol Biol (Paris); 1984 Feb; 32(2):139-43. PubMed ID: 6366709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [DNA index determined by flow cytometry in children with acute lymphoblastic leukemia as an additional diagnostic and prognostic element].
    Sikorska-Fic B; Wasik M; Rokicka-Milewska R
    Wiad Lek; 1998; 51 Suppl 4():103-6. PubMed ID: 10731951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Flow cytometry--use in cell biology and benefits in clinical medicine].
    Clausen OP; Olsen G; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2000 Feb; 120(4):489-95. PubMed ID: 10833942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
    Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
    Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia.
    Maloum K; Charlotte F; Divine M; Cazin B; Lesty C; Merle-Béral H;
    Haematologica; 2006 Jun; 91(6):860-1. PubMed ID: 16769593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A minimal residual population of leukemic cells in patients with acute myeloid leukemias].
    Gal'tseva IV; Parovichnikova EN; Savchenko VG
    Ter Arkh; 1997; 69(7):74-9. PubMed ID: 9424769
    [No Abstract]   [Full Text] [Related]  

  • 38. DNA flow-cytometry on fine needle aspiration cytology of lymph node: how helpful is it?
    Dey P; Saikia UN; Vohra H
    Indian J Pathol Microbiol; 2000 Apr; 43(2):127-30. PubMed ID: 11217267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical significance of fluorocytometry of the cell cycle in acute lymphoblastic leukemias in children].
    Demulder A; Ferster A; Fondu P
    Rev Med Brux; 1988 Oct; 9(7-8):367-74. PubMed ID: 3055136
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of the phenotype and cellular DNA content in some leukemias by flow cytometry.
    Kusenda J; Glasová M; Babusíková O
    Neoplasma; 1995; 42(6):347-52. PubMed ID: 8592578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.